Endocrine treatment of benign prostatichypertrophy: Current concepts
- 31 January 1991
- Vol. 37 (1) , 1-16
- https://doi.org/10.1016/0090-4295(91)80069-j
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Nafarelin Acetate and Benign Prostatic HyperplasiaNew England Journal of Medicine, 1988
- Aromatase inhibitors: Their biochemistry and clinical potentialJournal of Steroid Biochemistry, 1987
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- Aromatase inhibitors and benign prostatic hyperplasiaJournal of Steroid Biochemistry, 1986
- Effect of antiandrogen and/or antiestrogen blockade on human prostate epithelial and stromal cell protein synthesisJournal of Steroid Biochemistry, 1986
- Inhibition of androgen metabolism and binding by a liposterolic extract of “serenoa repens B” in human foreskin fibroblastsJournal of Steroid Biochemistry, 1984
- Correlative morphological and biochemical investigations on the stromal tissue of the human prostateJournal of Steroid Biochemistry, 1983
- Comparison of testosterone, 5α-dihydrotestosterone and 5α-androstane-3β,17β-diol metabolisms in human normal and hyperplastic prostatesThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- Prostate concentrations of endogenous androgens by radioimmunoassayJournal of Steroid Biochemistry, 1976
- Evaluation of Depostat R in prostatic adenoma on the ground of clinical and sphincterotonometric studiesInternational Urology and Nephrology, 1971